DK112888A - Aktiveret rnase l som markoer for virusinfektioner - Google Patents

Aktiveret rnase l som markoer for virusinfektioner

Info

Publication number
DK112888A
DK112888A DK112888A DK112888A DK112888A DK 112888 A DK112888 A DK 112888A DK 112888 A DK112888 A DK 112888A DK 112888 A DK112888 A DK 112888A DK 112888 A DK112888 A DK 112888A
Authority
DK
Denmark
Prior art keywords
pathway
rnase
aids
biochemical
inhibitor
Prior art date
Application number
DK112888A
Other languages
Danish (da)
English (en)
Other versions
DK112888D0 (da
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of DK112888D0 publication Critical patent/DK112888D0/da
Publication of DK112888A publication Critical patent/DK112888A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16HIV-1, HIV-2
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/922Ribonucleases (RNAses); Deoxyribonucleases (DNAses)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK112888A 1987-03-03 1988-03-02 Aktiveret rnase l som markoer for virusinfektioner DK112888A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2137287A 1987-03-03 1987-03-03

Publications (2)

Publication Number Publication Date
DK112888D0 DK112888D0 (da) 1988-03-02
DK112888A true DK112888A (da) 1988-09-04

Family

ID=21803819

Family Applications (1)

Application Number Title Priority Date Filing Date
DK112888A DK112888A (da) 1987-03-03 1988-03-02 Aktiveret rnase l som markoer for virusinfektioner

Country Status (20)

Country Link
EP (1) EP0285263B1 (es)
JP (1) JPH0675520B2 (es)
KR (1) KR880011593A (es)
AT (1) ATE107964T1 (es)
AU (1) AU618525B2 (es)
CA (1) CA1337278C (es)
DE (1) DE3850428T2 (es)
DK (1) DK112888A (es)
ES (1) ES2058252T3 (es)
FI (1) FI880959A (es)
IE (1) IE66831B1 (es)
IL (1) IL85576A0 (es)
MX (1) MX173802B (es)
NO (1) NO880934L (es)
NZ (1) NZ223721A (es)
OA (1) OA08720A (es)
PH (1) PH30882A (es)
PT (1) PT86878B (es)
RU (1) RU2049336C1 (es)
ZA (1) ZA881471B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
AU724056B2 (en) * 1987-09-04 2000-09-14 Hem Research, Inc. Diagnosis and treatment of double stranded deficiency states
DE3853755T2 (de) * 1987-09-04 1995-12-14 Hem Pharma Corp Diagnose von Mangelzuständen doppelsträngiger RNS.
ES2066847T3 (es) * 1988-07-07 1995-03-16 Hem Pharma Corp Diagnostico y tratamiento del sindrome de fatiga cronica.
US5985565A (en) * 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6080554A (en) * 1999-04-27 2000-06-27 R.E.D. Laboratories, N.V. Methods and compositions for use in characterizing multiple sclerosis disease activity in a subject
WO2017193051A1 (en) * 2016-05-06 2017-11-09 The Trustees Of Princeton University Methods of monitoring rnase l activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
CA1337278C (en) 1995-10-10
JPH0675520B2 (ja) 1994-09-28
OA08720A (en) 1989-03-31
EP0285263A2 (en) 1988-10-05
PH30882A (en) 1997-12-23
ES2058252T3 (es) 1994-11-01
ZA881471B (en) 1988-12-28
DK112888D0 (da) 1988-03-02
JPS63309200A (ja) 1988-12-16
DE3850428D1 (de) 1994-08-04
AU618525B2 (en) 1992-01-02
PT86878B (pt) 1992-05-29
PT86878A (pt) 1988-04-01
KR880011593A (ko) 1988-10-29
MX173802B (es) 1994-03-29
RU2049336C1 (ru) 1995-11-27
DE3850428T2 (de) 1994-11-24
FI880959A0 (fi) 1988-03-02
NO880934L (no) 1988-09-05
EP0285263A3 (en) 1990-04-18
EP0285263B1 (en) 1994-06-29
AU1256388A (en) 1988-09-01
IE880587L (en) 1988-09-03
NO880934D0 (no) 1988-03-02
IE66831B1 (en) 1996-02-07
ATE107964T1 (de) 1994-07-15
NZ223721A (en) 1991-02-26
IL85576A0 (en) 1988-08-31
FI880959A (fi) 1988-09-04

Similar Documents

Publication Publication Date Title
WO1994023041A3 (en) Method for selective inactivation of viral replication
DE69731548D1 (de) Verbundbogen mit gegengewicht
DK112888D0 (da) Aktiveret rnase l som markoer for virusinfektioner
MY138860A (en) Hiv protease inhibitors.
FI883763A (fi) Frigoering av vaerdens foersvarsmediatorer i biologiska vaetskor genom systematisk behandling med dubbelstraengat rna.
BR0005799A (pt) Sistema hidráulico
SE8601435L (sv) Aktivt pansar
CA2478527A1 (en) Arrangement for supporting a mortar shell into barrel of weapon and a method for attaching a support member to a mortar shell
ATE130760T1 (de) Synergistische wechselwirkung von interleukin-2 und doppelsträngiger rns.
DK112988D0 (da) Rnase l inhibitor som markoer for virusinfektioner
ATE74355T1 (de) Dihydrodibenzofuranderivate und diese verbindungen enthaltende fungizide.
AR247215A1 (es) Un procedimiento para producir un antibiotico antifungico y antiviral, n-acetilbenanomicina b.
NO985110L (no) Eksplosivformuleringer
DE69718911D1 (de) Interleukin - 8 als antivirale- und antitumorwirkstoffe
ES2004489A4 (es) Gametocidas de piridina.
SU968413A1 (ru) Раствор дл ослаблени горных пород
ES2007094A6 (es) Procedimiento para la preparacion de 3 -c- ciano-2,3 -didesoxinucleosido.
FI961105A (fi) Difluoristatoniviruksen vastaisia analogeja
AU1979283A (en) Nitroglycerine solution
IT1244893B (it) Utensile universale per sistema di tornitura esterna.
chromosome Y-Chromosom et al. Blastomyzet m. yellow I n 1.(Farbe) Gelb nt. 2. Ei
ES2093801T3 (es) Propenales sustituidos con un ciclo ditiano y procedimiento de preparacion de estos propenales.
BR7801990U (pt) Sistema compacto de captura e controle de baratas
JPS6431805A (en) Elimination of acrylonitrile in water or aqueous dispersion
KR900005991A (ko) 옥트레오티드(Octreotide)를 함유한 약학적 조성물

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment